Fingerstick at home – no collection point needed
- You receive a fingerstick kit with clear instructions
- Easily collect a few drops of blood yourself
- Return via medical mail to the lab
PSA (fingerstick)
PSA for prostate symptoms and screening in risk groups.
€26.95EUR
€5.95EUR
Costs are per order
- TrustPilot 4.6/5 sterren
- No GP referral needed
- Reviewed by BIG-registered physician
- ISO 15189 Certified laboratory
- At-home fingerstick collection
- Order today, ships today
Fingerstick at home – no collection point needed
- You receive a fingerstick kit with clear instructions
- Easily collect a few drops of blood yourself
- Return via medical mail to the lab
What is PSA?
PSA, or Prostate-Specific Antigen, is a protein primarily produced by the prostate gland. The level of PSA in the blood can aid in the detection of prostate conditions, including prostate cancer.
Why should you test PSA?
Testing PSA levels can be particularly useful for men above a certain age or for those with a family history of prostate cancer. Early detection of changes in PSA levels can be important for the timely diagnosis of prostate cancer or other prostate issues.
What does it indicate?
PSA levels in the blood can provide an indication of prostate health. While not every increase in PSA suggests cancer, higher levels can be a sign of prostate cancer, an enlarged prostate (benign prostatic hyperplasia), or prostate inflammation (prostatitis).
What does a high PSA level mean?
A high PSA level may indicate prostate cancer, but also benign prostatic hyperplasia or prostatitis. It is important to remember that PSA levels can also temporarily increase due to other factors, such as certain medical procedures, a urinary tract infection, or even intense physical activity.
What does a low PSA level mean?
A low PSA level is generally seen as an indication of a healthy prostate. It suggests that there are currently likely no significant prostate issues. However, it is important to continue regular check-ups, as PSA levels can change over time.
